| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 8, 2018 | RVTY Revvity, Inc. | Okun Andrew76 | Please See Remarks | Sell | 2,324 | $75.44 | $175,322.56 | -20.8% | |
| Feb 7, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 78,000 | $4.22 | $329,250.83 | +0.3% | |
| Feb 7, 2018 | TMO Thermo Fisher Scientific Inc. | Williamson Stephen68 | Sr. VP And CFO | Sell | 5,000 | $209.26 | $1,046,300.00 | -14.0% | |
| Feb 6, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 60,000 | $4.22 | $252,941.00 | +0.3% | |
| Feb 5, 2018 | RVTY Revvity, Inc. | Okun Andrew76 | See Remarks | Sell | 2,273 | $77.86 | $176,975.78 | -15.7% | |
| Feb 5, 2018 | TMO Thermo Fisher Scientific Inc. | Durbin Patrick M | Senior Vice President | Sell | 6,000 | $217.55 | $1,305,316.00 | -6.4% | |
| Feb 5, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 50,000 | $4.14 | $206,835.73 | +0.5% | |
| Feb 2, 2018 | DHR Danaher Corp /de/ | Lalor Angela S | SVP, Human Resources | Sell | 42,988 | $102.29 | $4,397,285.51 | -52.4% | |
| Feb 2, 2018 | TMO Thermo Fisher Scientific Inc. | Herrema Gregory J. | Senior Vice President | Sell | 33,327 | $219.70 | $7,321,941.90 | -55.1% | |
| Feb 2, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 55,000 | $4.30 | $236,679.75 | +0.4% | |
| Feb 2, 2018 | DHR Danaher Corp /de/ | Daniel William K | EVP | Sell | 131,066 | $102.05 | $13,374,877.20 | -31.0% | |
| Feb 1, 2018 | DHR Danaher Corp /de/ | Comas Daniel L | EVP &CFO | Sell | 62,989 | $101.96 | $6,422,106.48 | -27.7% | |
| Jan 31, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 65,000 | $4.47 | $290,415.90 | +0.5% | |
| Jan 29, 2018 | WAT Waters Corp /de/ | Rae Elizabeth B | SVP, Global Hr | Sell | 28,400 | $219.01 | $6,220,012.00 | -72.3% | |
| Jan 29, 2018 | A Agilent Technologies, Inc. | McMullen Michael R.63 | CEO And President | Sell | 21,850 | $75.00 | $1,638,750.00 | -6.7% | |
| Jan 26, 2018 | WAT Waters Corp /de/ | Beaudouin Mark T | SVP And General Counsel | Sell | 5,000 | $216.94 | $1,084,700.00 | -46.5% | |
| Jan 26, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 55,000 | $4.90 | $269,712.14 | +0.4% | |
| Jan 25, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 75,000 | $4.99 | $374,204.00 | +1.3% | |
| Jan 25, 2018 | WAT Waters Corp /de/ | Beaudouin Mark T | SVP And General Counsel | Sell | 42,143 | $217.21 | $9,153,843.95 | -64.7% | |
| Jan 24, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $4.89 | $488,828.50 | +0.8% | |
| Jan 23, 2018 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 110,439 | $50.49 | $5,575,960.53 | -3.0% | |
| Jan 23, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $4.76 | $476,070.00 | +20.2% | |
| Jan 22, 2018 | MYGN Myriad Genetics Inc | Marsh Richard M | E.v.p., General Counsel | Sell | 37,654 | $40.25 | $1,515,611.15 | -23.9% | |
| Jan 22, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $4.40 | $439,674.60 | +1.6% | |
| Jan 22, 2018 | MYGN Myriad Genetics Inc | King Gary A. | Exec. VP International Ops | Sell | 34,445 | $39.67 | $1,366,588.35 | -12.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.